Physician profile
Abhash Thakur
NPI 1457320129
$2,869.09
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $781 · 2020: $757 · 2021: $638 · 2022: $570 · 2023: $110 · 2024: $14.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $123.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $545.16 | 2020-2023 | Farxiga |
| Pfizer INC. | $446.57 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $367.14 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $360.68 | 2019-2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $342.72 | 2019-2022 | |
| Astellas Pharma US INC | $234.47 | 2019-2021 | |
| Allergan, INC. | $76.89 | 2019-2020 | |
| Boston Scientific Corporation | $60.00 | 2019 | |
| Merck Sharp & Dohme LLC | $57.21 | 2022 | |
| Hikma Pharmaceuticals USA | $50.01 | 2019-2020 | |
| Vifor Pharma, INC. | $45.64 | 2019 | |
| Abbvie INC. | $40.59 | 2021 | |
| Edwards Lifesciences Corporation | $36.51 | 2022 | |
| Chiesi USA, INC. | $33.57 | 2023-2024 | Kengreal |
| Amgen INC. | $24.22 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $22.21 | 2019 | |
| Ge Healthcare | $21.52 | 2022 | |
| Ambu INC. | $21.02 | 2022 | |
| Baxter Healthcare | $20.71 | 2022 | |
| Amarin Pharma, INC. | $19.05 | 2020 | |
| Stemline Therapeutics INC. | $16.58 | 2023 | Orserdu |
| Medtronic Vascular, INC. | $13.90 | 2019 | |
| Irhythm Technologies, INC. | $12.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhash Thakur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.